Get the Stockscreener App
16.39
4.80%
0.75
Si Bone Inc stock is traded at $16.39, with a volume of 333.63K.
It is up +4.80% in the last 24 hours and down -4.49% over the past month.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$15.64
Open:
$15.76
24h Volume:
333.63K
Relative Volume:
0.73
Market Cap:
$707.08M
Revenue:
$150.71M
Net Income/Loss:
$-40.85M
P/E Ratio:
-16.23
EPS:
-1.01
Net Cash Flow:
$-25.98M
1W Performance:
+6.02%
1M Performance:
-4.49%
6M Performance:
-8.13%
1Y Performance:
+10.00%
1-Day Range:
$15.55
$16.48
1-Week Range:
$15.39
$16.48
52-Week Range:
$11.70
$20.05
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
16.39 | 670.41M | 150.71M | -40.85M | -25.98M | -1.01 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
Sentiment Tools Show Shift in Trader Mood on SI BONE Inc.2025 Pullback Review & Weekly Momentum Stock Picks - classian.co.kr
Is SI BONE Inc. a speculative investmentWeekly Stock Report & Safe Capital Growth Plans - classian.co.kr
SI-BONE’s SWOT analysis: stock poised for growth amid market challenges By Investing.com - Investing.com South Africa
SI-BONE’s SWOT analysis: stock poised for growth amid market challenges - Investing.com Nigeria
SI BONE Inc. Shows Risk Reward Favoring Upside2025 Technical Overview & Weekly Momentum Picks - 선데이타임즈
Healthcare Analysts Bullish on SI-Bone, Delcath Systems, and Cardiol Therapeutics - AInvest
SI BONE Inc. Hits Price Floor — Bounce Incoming2025 Geopolitical Influence & Free Safe Capital Growth Stock Tips - beatles.ru
SI BONE Inc. Ranks High in Smart Money TrackerWeekly Stock Report & Smart Allocation Stock Reports - sundaytimes.kr
What makes SI BONE Inc. stock price move sharplyWeekly Massive Gain Alerts - thegnnews.com
SI BONE Inc. Stock Fails to Break Resistance Traders ReactJuly 2025 Final Week & Real-Time Volume Analysis - 선데이타임즈
Si-Bone at Canaccord Genuity: Strong Growth and Future Prospects By Investing.com - Investing.com Canada
SI-BONE stock price target reiterated at $25 by Cantor Fitzgerald - Investing.com Australia
Will SI BONE Inc. benefit from seasonalitySmart Entry for Explosive Returns - thegnnews.com
SI-BONE, Inc. (NASDAQ:SIBN) Q2 2025 Earnings Call Transcript - MSN
Dunn, director at Si-Bone, sells $5,090 in SIBN stock By Investing.com - Investing.com Australia
SI-BONE raises 2025 revenue guidance to $195M-$198M with accelerated cash flow milestones - MSN
Dunn, director at Si-Bone, sells $5,090 in SIBN stock - Investing.com
Further weakness as SI-BONE (NASDAQ:SIBN) drops 10% this week, taking five-year losses to 22% - simplywall.st
SI-BONE Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
SI-BONE 2025 Q2 Earnings Sustained Growth Amid Reduced Losses - AInvest
SI-BONE Reports Strong Q2 Growth and Raises Guidance - TipRanks
Si-Bone’s Earnings Call Highlights Strong Growth and Future Prospects - TipRanks
Si-Bone, Inc. shares fall 10.73% intraday after commercial leadership update. - AInvest
SI-BONE stock price target raised to $28 from $27 at Jefferies on strong Q2 - Investing.com Canada
Si-Bone Inc. Q2 Financial Results: Loss Narrows, Revenue Surpasses ForecastsNews and Statistics - IndexBox
SI-BONE, Inc. : Aiming for a Spot in Minimally Invasive Surgery - MarketScreener
SI-BONE Beats Revenue Forecasts As Doctors Embrace New Procedures - Finimize
SI-Bone’s Promising Financial Trajectory and Growth Potential Underpin Buy Rating - TipRanks
SI-BONE Inc (SIBN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Positive ... - Yahoo Finance
SI-BONE stock price target raised to $28 from $27 at Jefferies on strong Q2 By Investing.com - Investing.com South Africa
Technical analysis overview for SI BONE Inc. stockFree Secure Capital Picks With Upside Potential - Newser
Si-Bone: Q2 Earnings Snapshot - Norwalk Hour
SI-BONE Inc (SIBN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Positive ... By GuruFocus - Investing.com Canada
SI-BONE's Q2 2025 Earnings: A Turnaround Story with Strong Growth and Strategic Leadership Transition - AInvest
SI-BONE, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:SIBN) - Seeking Alpha
What risks could impact SI BONE Inc. stock performanceStock Market Trend and Pattern Analysis - Newser
Earnings call transcript: Si-Bone Q2 2025 beats earnings expectations By Investing.com - Investing.com Canada
Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Transcript : SI-BONE, Inc., Q2 2025 Earnings Call, Aug 04, 2025 - MarketScreener
SI-BONE Q2 2025 slides: Revenue jumps 22%, raises full-year guidance - Investing.com Australia
SI-BONE Q2 2025 slides: Revenue jumps 22%, raises full-year guidance By Investing.com - Investing.com South Africa
Why SI BONE Inc. stock attracts strong analyst attentionAlgorithmic Forecast for Swing Trading Picks - Newser
Medical device firm SI-BONE Q2 revenue beats estimates - MarketScreener
SI-Bone Reports Strong Q2 2025 Financial Results - TipRanks
Si-Bone earnings beat by $0.04, revenue topped estimates - Investing.com Canada
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance - The Manila Times
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Si Bone Inc Stock (SIBN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr |
Aug 18 '25 |
Sale |
15.64 |
3,329 |
52,055 |
258,352 |
| Maheshwari Anshul | Chief Financial Officer |
Aug 18 '25 |
Sale |
15.57 |
3,461 |
53,881 |
214,445 |
| FRANCIS LAURA | Chief Executive Officer |
Aug 18 '25 |
Sale |
15.60 |
11,343 |
176,940 |
419,704 |
| Freund John Gordon | Director |
Aug 08 '25 |
Sale |
15.99 |
12,132 |
193,998 |
91,767 |
| DUNN JEFFREY W | Director |
Aug 04 '25 |
Sale |
17.37 |
293 |
5,091 |
11,647 |
| FRANCIS LAURA | Chief Executive Officer |
Jul 07 '25 |
Sale |
18.26 |
757 |
13,823 |
362,141 |
| Maheshwari Anshul | Chief Financial Officer |
Jul 02 '25 |
Sale |
18.34 |
5,005 |
91,811 |
217,078 |
| RECUPERO ANTHONY J | President, Commercial Ops |
Jul 02 '25 |
Sale |
18.27 |
3,310 |
60,476 |
279,121 |
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr |
Jul 02 '25 |
Sale |
18.29 |
3,127 |
57,203 |
261,681 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):